Literature DB >> 26993825

Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Veeravich Jaruvongvanich1,2, Anawin Sanguankeo3,4, Sikarin Upala5,6.   

Abstract

BACKGROUND: Gallstone disease (GD) and nonalcoholic fatty liver disease (NAFLD) are common digestive disorders worldwide. Both conditions share certain risk factors including obesity, insulin resistance and diabetes. Several epidemiologic studies have reported the relationship between these two conditions. AIM: We conducted a systematic review and meta-analysis to characterize the association between GD and NAFLD.
METHODS: A comprehensive search of the databases MEDLINE and EMBASE was performed from inception through November 2015. The inclusion criterion was the observational studies' assessment of the association between GD and NAFLD in adult participants. Pooled odds ratio (OR) and 95 % confidence interval (CI) were calculated using a random-effects model.
RESULTS: Data were extracted from 12 observational studies (9 cross-sectional studies, 1 case-control study and 2 cohort studies). The pooled OR of NAFLD in patients who had GD was 1.55 (95 % CI 1.31-1.82). The statistical between-studies heterogeneity (I (2)) was 64 %. The association remained significant when limited to cohort studies with pooled OR 1.33 (95 % CI 1.14-1.55, I (2) = 0 %).
CONCLUSION: Our meta-analysis demonstrated that GD is significantly associated with NAFLD. Further prospective studies exploring the underlying mechanism of this association should be pursued.

Entities:  

Keywords:  Cholelithiasis; Gallstones; Insulin resistance; Meta-analysis; Nonalcoholic fatty liver disease

Mesh:

Year:  2016        PMID: 26993825     DOI: 10.1007/s10620-016-4125-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  47 in total

1.  Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.

Authors:  Yen-Chun Lee; Jin-Shang Wu; Yi-Ching Yang; Chin-Sung Chang; Feng-Hwa Lu; Chih-Jen Chang
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

2.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

3.  Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

Authors:  Chien-Hua Chen; Min-Ho Huang; Jee-Chun Yang; Chiu-Kue Nien; Gina Doskey Etheredge; Chi-Chieh Yang; Yung-Hsiang Yeh; Hurng-Sheng Wu; Der-Aur Chou; Sen-Kou Yueh
Journal:  J Gastroenterol Hepatol       Date:  2006-11       Impact factor: 4.029

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 5.  Cholesterol gallstone disease.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Palasciano
Journal:  Lancet       Date:  2006-07-15       Impact factor: 79.321

6.  Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.

Authors:  Srinevas K Reddy; Min Zhan; H Richard Alexander; Samer S El-Kamary
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

7.  Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China.

Authors:  Fen-Ming Zhang; Chao-Hui Yu; Hong-Tan Chen; Zhe Shen; Feng-Ling Hu; Xiao-Ping Yuan; Guo-Qiang Xu
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 8.  Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?

Authors:  Mohamed H Ahmed; Asif Ali
Journal:  Scand J Gastroenterol       Date:  2014-03-20       Impact factor: 2.423

9.  Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan.

Authors:  Jau-Yuan Chen; Chung-Te Hsu; Jorn-Hon Liu; Tao-Hsin Tung
Journal:  BMC Gastroenterol       Date:  2014-04-28       Impact factor: 3.067

10.  Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population.

Authors:  Jia Liu; Haiyan Lin; Chengqi Zhang; Lu Wang; Shuo Wu; Dongzhi Zhang; Fang Tang; Fuzhong Xue; Yanxun Liu
Journal:  BMC Gastroenterol       Date:  2014-12-13       Impact factor: 3.067

View more
  16 in total

Review 1.  Mouse models of gallstone disease.

Authors:  Tony Y Wang; Piero Portincasa; Min Liu; Patrick Tso; David Q-H Wang
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

Review 2.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

3.  Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Sikarin Upala
Journal:  Eur Thyroid J       Date:  2017-01-21

4.  Epidemiological survey to determine the prevalence of cholecystolithiasis in Uyghur, Kazakh, and Han Ethnic Groups in the Xinjiang Uyghur Autonomous Region of China: cross-sectional studies.

Authors:  Fujun Lv; Guangjun Wang; Dandan Ding; Jiangwei Liu; Caifu Shen; Feng Ji; Yan Kang
Journal:  BMC Gastroenterol       Date:  2021-03-18       Impact factor: 3.067

Review 5.  Nonalcoholic fatty liver disease: Evolving paradigms.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Mauro Maurantonio; Alessandra Marrazzo; Luca Rinaldi; Luigi Elio Adinolfi
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

6.  Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study.

Authors:  Masood Sepehrimanesh; Ramin Niknam; Fardad Ejtehadi; Mohammad Reza Fattahi; Alireza Safarpour
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-01       Impact factor: 3.168

7.  Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study.

Authors:  Yoosoo Chang; Yoo-Hun Noh; Byung-Seong Suh; Yejin Kim; Eunju Sung; Hyun-Suk Jung; Chan-Won Kim; Min-Jung Kwon; Kyung Eun Yun; Jin-Won Noh; Hocheol Shin; Yong Kyun Cho; Seungho Ryu
Journal:  J Clin Med       Date:  2018-11-21       Impact factor: 4.241

Review 8.  Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Authors:  Li Qi; Wanlin Dai; Jing Kong; Yu Tian; Yongsheng Chen
Journal:  J Physiol Biochem       Date:  2021-07-24       Impact factor: 4.158

9.  Cholelithiasis and choledocholithiasis in children; risk factors for development.

Authors:  Barbora Frybova; Jiri Drabek; Jindra Lochmannova; Ladislav Douda; Stepan Hlava; Daniela Zemkova; Vladimir Mixa; Martin Kyncl; Lubos Zeman; Michal Rygl; Radan Keil
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

10.  Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis.

Authors:  Hong Chen; Wei-Ke Zeng; Guang-Zi Shi; Ming Gao; Meng-Zhu Wang; Jun Shen
Journal:  World J Gastroenterol       Date:  2020-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.